Advanced search
Publication Cover
Current Medical Research and Opinion Volume 36, 2020 - Issue 4
Submit an article Journal homepage
2,100
Views
5
CrossRef citations to date
0
Altmetric
Cardiovascular Medicine

Healthcare resource utilization and costs among nonvalvular atrial fibrillation patients initiating rivaroxaban or warfarin in skilled nursing facilities: a retrospective cohort study

V. Simon Mittala Advanced Health Institute and LTC Professionals, Bloomington, MN, USACorrespondence[email protected]
,
Bingcao Wub Janssen Scientific Affairs, LLC, Titusville, NJ, USA
,
Ji Songb Janssen Scientific Affairs, LLC, Titusville, NJ, USA
,
Dejan Milentijevicb Janssen Scientific Affairs, LLC, Titusville, NJ, USA
,
Veronica Ashtonb Janssen Scientific Affairs, LLC, Titusville, NJ, USA
&
Dheeraj Mahajanc University of Illinois at Chicago and Advocate Illinois Masonic Medical Center, Melrose Park, IL, USA
Pages 529-536 | Received 08 Nov 2019, Accepted 16 Dec 2019, Published online: 09 Jan 2020

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

William L. Baker, Matthew S. Roberts, Youssef Bessada, Kimberly S. Caroti, Veronica Ashton, Brahim K. Bookhart & Craig I. Coleman. (2023) Comparative outcomes associated with rivaroxaban versus warfarin use in elderly patients with atrial fibrillation or acute venous thromboembolism managed in the United States: a systematic review of observational studies. Current Medical Research and Opinion 39:9, pages 1183-1194.
Read now

Articles from other publishers (4)

Jeffrey S. Berger, Veronica Ashton, François Laliberté, Guillaume Germain, Brahim Bookhart, Dominique Lejeune, Julien Boudreau, Patrick Lefebvre & Matthew R. Weir. (2023) Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Non-valvular Atrial Fibrillation (NVAF) Patients with Diabetes in a US Population. Advances in Therapy 40:3, pages 1224-1241.
Crossref
Lorenzo G. Mantovani, Paolo Cozzolino, Pietro Ferrara, Saverio Virdone, A. John Camm, Freek W. A. Verheugt, Jean-Pierre Bassand, Alexander G. G. Turpie, Werner Hacke, Gloria Kayani, Samuel Z. Goldhaber, Shinya Goto, Karen S. Pieper, Bernard J. Gersh, Keith A. A. Fox, Sylvia Haas, Martin van Eickels & Ajay K. Kakkar. (2023) Healthcare Resource Utilization in Patients with Newly Diagnosed Atrial Fibrillation: A Global Analysis from the GARFIELD-AF Registry. Healthcare 11:5, pages 638.
Crossref
François Laliberté, Veronica Ashton, Akshay Kharat, Dominique Lejeune, Kenneth Todd Moore, Young Jung, Patrick Lefebvre & Jeffrey S Berger. (2021) Economic burden of rivaroxaban and warfarin among nonvalvular atrial fibrillation patients with obesity and polypharmacy. Journal of Comparative Effectiveness Research 10:16, pages 1235-1250.
Crossref
Wen Jun Tiew, Vivien LX Wong, Vern Hsen Tan, Yong Chuan Tan & Elena MS Lee. (2020) A Real-world Experience of the Safety and Efficacy of Non-vitamin K Oral Anticoagulants Versus Warfarin in Patients with Non-valvular Atrial Fibrillation— A Single-centre Retrospective Cohort Study in Singapore. Annals of the Academy of Medicine, Singapore 49:11, pages 838-847.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.